Anavex Life Sciences Corp (AVXL)

[JWC3]

Right on. The 25% short overhang is effective hold down now! It won’t be when ANAVEX gets APPROVAL for ALZHEIMER’S in record time after all the data is revealed for AD. The data has been reported in summary form and it is outstanding! The naysayers just deny deny w/o reason and against ALL odds! The revenue of $10+B per year from ALZHEIMER’S alone will drive the $AVXL stock price well above $200 instantly! Nothing more needs to be reported publically. ANAVEX will perform this way exactly as has already been reported.